Allergan is a global, technology-driven, multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful treatments. Helping people reach their life's potential, to see more clearly; move more freely; and express themselves more fully.
We have highly dedicated and talented employees, global marketing and sales capabilities with a presence in more than 100 countries. Allergan's portfolio features 6 franchises in key therapeutic categories including Dermatology and Medical Aesthetics, CNS, Eye Care, Women's Health and Urology, GI and Cystic Fibrosis, Cardiovascular and Infectious Disease.
Allergan is proud to celebrate more than 60 years of medical advances and proud to support the patients and physicians who rely on our products as well as the employees and communities in which we live and work.
Boston Scientific (NYSE: BSX) transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
We are dedicated to transforming the lives of patients by delivering meaningful innovations for the most challenging neurological disorders. A leading provider and developer of high performance Neuromodulation therapies, we have a long history of closely collaborating with neurosurgeons and pain physicians who treat neurological disorders.
With approximately 3000 employees and a direct presence in 28 countries, Merz is a global, family-owned aesthetics and neurotoxin company inspired by more than 110 years of innovation, commitment and trust. Driven by the opportunity to help people look better, feel better and live better, Merz earns the confidence of clinicians in aesthetics and neuroscience with a relentless focus on customer service to providers and overall satisfaction for patients.
As a family-owned company, Merz values personal relationships; we recognize that our obligation is to understand the needs of our physician customers, so we can help them best serve their patients. You see it in how we engage with our customers in every aspect of our business. You see it in our holistic portfolio of products. And you'll see it in the innovations that are already expanding that portfolio.
From our scientific expertise developed over more than a century, to our focus on customer needs, the Merz way means your success is our success.
In fiscal year 2016/2017 Merz generated revenue of EUR 1,023.2m. More information can be found at www.merzaustralia.com.au
At Pfizer, we believe that innovation comes from working in partnership with others. We are innovating to bring therapies to patients that allow them to live better and longer lives and vaccines to prevent them from becoming sick in the first place.
We are proud to be part of an industry that has helped treat, cure and eradicate life-threatening diseases. We play an active role across the Australian healthcare spectrum working with patient organisations and government for the benefit of each patient.
Since 1956, our people have worked together with our partners for the sole purpose of ensuring that Australians can access new and innovative medicines to extend and improve life. We are proud of our history and look forward with enthusiasm to the future.